Daniel H. Geschwind, M.D., Ph.D.


Director, Center for Autism Research and Treatment (CART)

Gordon and Virginia MacDonald Distinguished Chair, Human Genetics

Professor, Neurology

Psychiatry and Biobehavioral Sciences

Co-Director, Center for Neurobehavioral Genetics

Professor In-Residence, Tennenbaum Center for the Biology of Creativity

Human Genetics

Member, Bioinformatics GPB Home Area

Brain Research Institute


Genetics & Genomics GPB Home Area

Neuroscience GPB Home Area

Workforce Development

Awards and Honors:

UCLA School of Medicine, Los Angeles

UCLA School of Medicine, Los Angeles

UCLA School of Medicine, Los Angeles

Contact Information

Fax Number: (310) 267-2401
Lab Number: (310) 794-7537
Office Phone Number: (310) 794-6570

Mailing Address:

695 Charles E Young Dr South
Los Angeles, CA 90095

Office Address:

695 Charles E Young Dr South
Los Angeles, CA 90095


Dr. Daniel Geschwind is the Gordon and Virginia MacDonald Distinguished Professor of of neurology, psychiatry and human genetics at the UCLA School of Medicine. He directs the Neurogenetics Program in the department of Neurology and the Center for Autism Research and Treatment (CART), which is unique in housing 3 Autism Center of Excellence (ACE) Awards from the NIH.

Dr. Geschwind obtained an A.B. in chemistry and psychology (modified) at Dartmouth College, followed by 2 years as a research associate at the Boston Consulting Group. He subsequently obtained his M.D./Ph.D. at Yale School of Medicine (AOA) prior to completing his internship, residency (Neurology), and postdoctoral fellowship at UCLA.

He joined the UCLA faculty in 1997, founding the neurogenetics program. Since then, his laboratory has focused on integrating genetics and genomics with basic neurobiology, relying heavily on computational and bioinformatic methods in addition to wet laboratory experimentation. The ultimate goal is to use these integrative approaches to help develop effective therapeutics for neurologic and psychiatric disorders, including autism and neurodegenerative dementia. One key aspect of his efforts has been the development and application of new analytic methods that elucidate the underlying network organization in multi-dimensional data, permitting integration of genomic and genetic data with phenotype data on a large scale. This has enabled the lab to begin to successfully connect genetic risk for disease in autism to brain circuitry and molecular function both in humans, and in vitro and in vivo model systems. Dr. Geschwind has also put considerable effort into fostering large-scale collaborative patient resources for genetic research and data sharing. He is a strong advocate for data and biomaterial sharing, having provided scientific oversight for the Autism Genetic Resource Exchange (AGRE). He has served on numerous scientific advisory boards, including the Faculty of 1000 Medicine, the Executive Committee of the American Neurological Association, the Neurogenetics Section (founding member and former chair) of the American Academy of Neurology, the NIMH Advisory Council, and the NIH Council of Councils.

He has published over 300 papers and serves on the editorial boards of several journals including Biological Psychiatry, Cell, Neurobiology of Disease, Human Molecular Genetics, Neuron and Science. He received the Derek Denny-Brown Neurological Scholar Award from the American Neurological Association in 2004, the Scientific Service Award from Autism Speaks, a MERIT award from NIMH, the Ruane Prize for Child and Adolescent Psychiatric Research from the Brain and Behavior foundation, and the Taking on Tommorow Innovation Award (for research/scientific breakthrough in autism)” from the Boston Children’s Hospital. He is a member of the American Association of Physicians and a member of the Institute of Medicine of the U.S. National Academies.